BIO-key Raises $2.51M via Warrant Exercise, Issues New Warrants at $4.06
BKYI sits 20% above its 52-week low of $3.1.
Summary
BIO-key raised $2.51 million by inducing an institutional investor to exercise existing warrants at a reduced price, in exchange for new warrants covering twice as many shares.
Updates
· SEC PRE 14A — The proxy supplement adds Proposal 4 for the September 3 annual meeting to approve issuance of up to 1,236,668 shares upon exercise of the new warrants, with full exercise diluting existing holders by about 53.2%.
Key Events · Financing and Capital Events · BKYI
-
Warrant Exercise Agreement
BIO-key entered into an agreement with Armistice Capital to exercise 618,334 existing warrants at a reduced price of $4.06 per share, down from $10.20.
-
New Warrants Issued
In exchange, the investor received 1,236,668 new warrants with an exercise price of $4.06, subject to shareholder approval and a 4.99% beneficial ownership limitation.
-
Proceeds and Use
Gross proceeds were approximately $2.51 million, before placement agent fees of 5.0% to Maxim Group LLC. Proceeds will fund working capital and may repay a portion of the outstanding secured note.
-
Shareholder Approval Required
The company must hold a shareholder meeting within 120 days to approve the exercisability of the new warrants, with subsequent meetings every 90 days if approval is not obtained.
Analysis · BKYI · Technology
BIO-key entered into a warrant exercise agreement with Armistice Capital, reducing the exercise price of 618,334 existing warrants from $10.20 to $4.06 and issuing 1,236,668 new warrants at the same price. The company received approximately $2.51 million in gross proceeds, which will be used for working capital and possibly debt repayment. The new warrants are subject to shareholder approval and carry a 4.99% beneficial ownership limitation. This financing provides needed liquidity but adds potential future dilution if the new warrants are exercised.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BKYI was trading at $3.73 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $3.10 to $19.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.